{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T07:58:22Z","timestamp":1789286302975,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015675","name":"National Blood Authority","doi-asserted-by":"publisher","award":["ID 403"],"award-info":[{"award-number":["ID 403"]}],"id":[{"id":"10.13039\/100015675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with cirrhosis often undergo invasive procedures both for management of complications of their advanced liver disease, including treatment for hepatocellular carcinoma, as well as underlying comorbidities. Despite a current understanding that most patients with cirrhosis are in a rebalanced haemostatic state (despite abnormalities in conventional coagulation tests, namely INR and platelet count), patients with cirrhosis are still often given prophylactic blood components based on these conventional parameters, in an effort to reduce procedure-related bleeding. Viscoelastic tests such as Rotational Thromboelastometry (ROTEM) provide a global measurement of haemostasis and have been shown to predict bleeding risk more accurately than conventional coagulation tests, and better guide blood product transfusion in a number of surgical and trauma-related settings. The aim of this study is to assess the utility of a ROTEM-based algorithm to guide prophylactic blood component delivery in patients with cirrhosis undergoing invasive procedures. We hypothesise that ROTEM-based decision-making will lead to a reduction in pre-procedural blood component usage, particularly fresh frozen plasma (FFP), compared with standard of care, whilst maintaining optimal clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a multi-centre randomised controlled trial comparing ROTEM-guided prophylactic blood component administration to standard of care in patients with cirrhosis and coagulopathy undergoing invasive procedures. The primary efficacy outcome of the trial is the proportion of procedures requiring prophylactic transfusion, with the primary safety outcome being procedure-related bleeding complications. Secondary outcomes include the amount of blood products (FFP, platelets, cryoprecipitate) transfused, transfusion-related side effects, procedure-related complications other than bleeding, hospital length of stay and survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We anticipate that this project will lead to improved prognostication of patients with cirrhosis, in terms of their peri-procedural bleeding risk. We hope to show that a significant proportion of cirrhotic patients, deemed coagulopathic on the basis of standard coagulation tests such as INR and platelet count, are actually in a haemostatic balance and thus do not require prophylactic blood product, leading to decreased and more efficient blood component use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>RECIPE has been prospectively registered with the Australia and New Zealand Clinical Trials Registry\u00a0on the 30th April 2019\u00a0(<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12619000644167\">ACTRN12619000644167<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07552-1","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T14:02:25Z","timestamp":1691762545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5693-0248","authenticated-orcid":false,"given":"Natasha","family":"Janko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart K.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"6","key":"7552_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jvir.2012.02.012","volume":"23","author":"IJ Patel","year":"2012","unstructured":"Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727\u201336.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"7552_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","volume":"116","author":"T Lisman","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878\u201385.","journal-title":"Blood"},{"issue":"5","key":"7552_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/MOH.0000000000000164","volume":"22","author":"A Tripodi","year":"2015","unstructured":"Tripodi A. Hemostasis abnormalities in cirrhosis. Curr Opin Hematol. 2015;22(5):406\u201312.","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"7552_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/liv.13056","volume":"36","author":"EM Fatourou","year":"2016","unstructured":"Fatourou EM, Tsochatzis EA. Transfusion strategies in patients with cirrhosis: less is more. Liver Int. 2016;36(4):503\u20134.","journal-title":"Liver Int"},{"issue":"9","key":"7552_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11894-017-0585-6","volume":"19","author":"N Zakeri","year":"2017","unstructured":"Zakeri N, Tsochatzis EA. Bleeding risk with invasive procedures in patients with cirrhosis and coagulopathy. Curr Gastroenterol Rep. 2017;19(9):45.","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"7552_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.21303","volume":"44","author":"SH Caldwell","year":"2006","unstructured":"Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44(4):1039\u201346.","journal-title":"Hepatology"},{"issue":"3","key":"7552_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743\u201352.","journal-title":"J Hepatol"},{"issue":"1","key":"7552_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ajg.2008.34","volume":"104","author":"KK Sogaard","year":"2009","unstructured":"Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol. 2009;104(1):96\u2013101.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"7552_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1537-2995.2005.00546.x","volume":"45","author":"JB Segal","year":"2005","unstructured":"Segal JB, Dzik WH, Transfusion Medicine\/Hemostasis Clinical Trials N. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45(9):1413\u201325.","journal-title":"Transfusion"},{"issue":"10","key":"7552_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cgh.2010.06.018","volume":"8","author":"EG Giannini","year":"2010","unstructured":"Giannini EG, Greco A, Marenco S, Andorno E, Valente U, Savarino V. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010;8(10):899\u2013902.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"7552_CR11","doi-asserted-by":"publisher","first-page":"e13508","DOI":"10.1111\/eci.13508","volume":"51","author":"D Alvaro","year":"2021","unstructured":"Alvaro D, Caporaso N, Giannini EG, Iacobellis A, Morelli M, Toniutto P, et al. Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia. Eur J Clin Invest. 2021;51(6):e13508.","journal-title":"Eur J Clin Invest"},{"key":"7552_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","volume":"38","author":"G Napolitano","year":"2017","unstructured":"Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, et al. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. Eur J Intern Med. 2017;38:79\u201382.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"7552_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ajg.2017.457","volume":"113","author":"S Basili","year":"2018","unstructured":"Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, et al. Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study. Am J Gastroenterol. 2018;113(3):368\u201375.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"7552_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.20569","volume":"41","author":"A Tripodi","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553\u20138.","journal-title":"Hepatology"},{"issue":"5","key":"7552_CR15","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","volume":"161","author":"RS O\u2019Shea","year":"2021","unstructured":"O\u2019Shea RS, Davitkov P, Ko CW, Rajasekhar A, Su GL, Sultan S, et al. AGA clinical practice guideline on the management of coagulation disorders in patients with cirrhosis. Gastroenterology. 2021;161(5):1615-27 e1.","journal-title":"Gastroenterology"},{"issue":"5","key":"7552_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","volume":"76","author":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L","year":"2022","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol. 2022;76(5):1151\u201384.","journal-title":"J Hepatol"},{"issue":"1","key":"7552_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.31646","volume":"73","author":"PG Northup","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases. Hepatology. 2021;73(1):366\u2013413.","journal-title":"Hepatology"},{"issue":"5","key":"7552_CR18","doi-asserted-by":"publisher","first-page":"e0147","DOI":"10.1097\/HC9.0000000000000147","volume":"7","author":"N Janko","year":"2023","unstructured":"Janko N, Majeed A, Clements W, Fink MA, Lubel J, Goodwin M, et al. Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey. Hepatol Commun. 2023;7(5):e0147.","journal-title":"Hepatol Commun"},{"issue":"2","key":"7552_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MEG.0000000000001948","volume":"34","author":"N Janko","year":"2022","unstructured":"Janko N, Majeed A, Commins I, Kemp W, Roberts SK. Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis. Eur J Gastroenterol Hepatol. 2022;34(2):192\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"7552_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep.30561","volume":"70","author":"M Peck-Radosavljevic","year":"2019","unstructured":"Peck-Radosavljevic M, Simon K, Iacobellis A, Hassanein T, Kayali Z, Tran A, et al. Lusutrombopag for the treatment of thrombocytopenia in patients with chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2). Hepatology. 2019;70(4):1336\u201348.","journal-title":"Hepatology"},{"issue":"5","key":"7552_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2036.2005.02387.x","volume":"21","author":"I Pache","year":"2005","unstructured":"Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005;21(5):525\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"7552_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1378\/chest.12-2374","volume":"144","author":"RM Hibbert","year":"2013","unstructured":"Hibbert RM, Atwell TD, Lekah A, Patel MD, Carter RE, McDonald JS, et al. Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. Chest. 2013;144(2):456\u201363.","journal-title":"Chest"},{"issue":"8","key":"7552_CR23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/liv.14936","volume":"41","author":"A Mohanty","year":"2021","unstructured":"Mohanty A, Kapuria D, Canakis A, Lin H, Amat MJ, Rangel Paniz G, et al. Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study. Liver Int. 2021;41(8):1901\u20138.","journal-title":"Liver Int"},{"issue":"2","key":"7552_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/gut.15.2.99","volume":"15","author":"DS Zimmon","year":"1974","unstructured":"Zimmon DS, Kessler RE. The portal pressure-blood volume relationship in cirrhosis. Gut. 1974;15(2):99\u2013101.","journal-title":"Gut"},{"issue":"7","key":"7552_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/liv.12158","volume":"33","author":"SV Mallett","year":"2013","unstructured":"Mallett SV, Chowdary P, Burroughs AK. Clinical utility of viscoelastic tests of coagulation in patients with liver disease. Liver Int. 2013;33(7):961\u201374.","journal-title":"Liver Int"},{"issue":"4","key":"7552_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4097\/kja.19169","volume":"72","author":"K Gorlinger","year":"2019","unstructured":"Gorlinger K, Perez-Ferrer A, Dirkmann D, Saner F, Maegele M, Calatayud AAP, et al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol. 2019;72(4):297\u2013322.","journal-title":"Korean J Anesthesiol"},{"issue":"1","key":"7552_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13049-017-0378-9","volume":"25","author":"M Fahrendorff","year":"2017","unstructured":"Fahrendorff M, Oliveri RS, Johansson PI. The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products - A systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2017;25(1):39.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"2","key":"7552_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.28148","volume":"63","author":"L De Pietri","year":"2016","unstructured":"De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology. 2016;63(2):566\u201373.","journal-title":"Hepatology"},{"issue":"7","key":"7552_CR29","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1007\/s10620-019-05939-2","volume":"65","author":"SK Vuyyuru","year":"2020","unstructured":"Vuyyuru SK, Singh AD, Gamanagatti SR, Rout G, Gunjan D, Shalimar. A Randomized control trial of thromboelastography-guided transfusion in cirrhosis for high-risk invasive liver-related procedures. Dig Dis Sci. 2020;65(7):2104\u201311.","journal-title":"Dig Dis Sci."},{"issue":"11","key":"7552_CR30","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1111\/liv.15398","volume":"42","author":"A Maria","year":"2022","unstructured":"Maria A, Lal BB, Khanna R, Sood V, Mukund A, Bajpai M, et al. Rotational thromboelastometry-guided blood component use in cirrhotic children undergoing invasive procedures: randomized controlled trial. Liver Int. 2022;42(11):2492\u2013500.","journal-title":"Liver Int"},{"issue":"8","key":"7552_CR31","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1055\/s-0038-1666861","volume":"118","author":"NM Intagliata","year":"2018","unstructured":"Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F, et al. Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th International coagulation in liver disease conference. Thromb Haemost. 2018;118(8):1491\u2013506.","journal-title":"Thromb Haemost"},{"key":"7552_CR32","doi-asserted-by":"crossref","unstructured":"O\u2019Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019;157(1):34-43 e1.","DOI":"10.1053\/j.gastro.2019.03.070"},{"issue":"1","key":"7552_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202\u20134.","journal-title":"J Thromb Haemost"},{"key":"7552_CR34","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"issue":"2","key":"7552_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"7552_CR36","unstructured":"Guidance: Safety monitoring and reporting in clinical trials involving therapeutic goods. National Health and Medical Research Council. 2016. Cited April 20, 2023. Available from: https:\/\/www.nhmrc.gov.au\/guidelines-publications\/eh59."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07552-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:33:39Z","timestamp":1700400819000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07552-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7552"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07552-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval has been obtained by The Alfred Ethics Committee, study no 271\/19. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"A model consent form may be provided on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"516"}}